Cann Group Ltd (CAN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.000x

Based on the latest financial reports, Cann Group Ltd (CAN) has a cash flow conversion efficiency ratio of 0.000x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-11.00K ≈ $-7.78K USD) by net assets (AU$34.16 Million ≈ $24.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CAN defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Cann Group Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Cann Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cann Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cann Group Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Joe Holding Bhd KLSE:7096	-0.016x
Carmell Therapeutics Corporation NASDAQ:CTCX	0.198x
Polar Capital Global Financials Trust plc LSE:PCFT	0.010x
Duksung Co Ltd KO:004835	0.003x
Fidelity Asian Values LSE:FAS	0.000x
FP Newspapers Inc V:FP	-0.011x
DSS Inc NYSE MKT:DSS	-0.290x
INTL SCHOOL AUGS.AG NA ON F:9JK	N/A

Annual Cash Flow Conversion Efficiency for Cann Group Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Cann Group Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see CAN company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-2.77 Million ≈ $-1.96 Million	AU$-9.64 Million ≈ $-6.82 Million	3.475x	+418.57%
2024-06-30	AU$13.92 Million ≈ $9.85 Million	AU$-15.19 Million ≈ $-10.74 Million	-1.091x	-183.08%
2023-06-30	AU$59.26 Million ≈ $41.93 Million	AU$-22.84 Million ≈ $-16.16 Million	-0.385x	-60.11%
2022-06-30	AU$84.90 Million ≈ $60.07 Million	AU$-20.43 Million ≈ $-14.46 Million	-0.241x	-6.15%
2021-06-30	AU$91.87 Million ≈ $65.01 Million	AU$-20.83 Million ≈ $-14.74 Million	-0.227x	+21.40%
2020-06-30	AU$61.07 Million ≈ $43.21 Million	AU$-17.62 Million ≈ $-12.47 Million	-0.288x	-200.42%
2019-06-30	AU$77.30 Million ≈ $54.69 Million	AU$-7.42 Million ≈ $-5.25 Million	-0.096x	-119.63%
2018-06-30	AU$85.87 Million ≈ $60.76 Million	AU$-3.75 Million ≈ $-2.66 Million	-0.044x	+72.12%
2017-06-30	AU$14.66 Million ≈ $10.37 Million	AU$-2.30 Million ≈ $-1.63 Million	-0.157x	+78.75%
2016-06-30	AU$1.69 Million ≈ $1.20 Million	AU$-1.25 Million ≈ $-882.14K	-0.738x	+25.57%
2015-06-30	AU$648.33K ≈ $458.73K	AU$-642.74K ≈ $-454.78K	-0.991x	--

About Cann Group Ltd

AU:CAN Australia Drug Manufacturers - Specialty & Generic

Market Cap

$4.60 Million

AU$6.50 Million AUD

Market Cap Rank

#28717 Global

#1566 in Australia

Share Price

AU$0.00

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.02

All Time High

AU$3.98